Learn More
PeproTech RANKL (soluble) Polyclonal Antibody, Biotin, PeproTech®, Invitrogen™
Rabbit Polyclonal Antibody
£177.00 - £2745.00
Specifications
| Antigen | RANKL (soluble) |
|---|---|
| Concentration | 0.1-1.0 mg/mL |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Conjugate | Biotin |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
17824323
|
PeproTech
500-P133BT-25UG |
25 μg |
£177.00
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
17824713
|
PeproTech
500-P133BT-50UG |
50 μg |
£228.00
50µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
17834713
|
Invitrogen
500-P133BT-1MG |
2 x 500 μg | |||||||
|
30054506
|
PeproTech
500-P133BT-500UG |
500 μg |
£1466.00
500µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
AA Sequence of recombinant protein: MEKAMVDGSW LDLAKRSKLE AQPFAHLTIN ATDIPSGSHK VSLSSWYHDR GWAKISNMTF SNGKLIVNQD GFYYLYANIC FRHHETSGDL ATEYLQLMVY VTKTSIKIPS SHTLMKGGST KYWSGNSEFH FYSINVGGFF KLRSGEEISI EVSNPSLLDP DQDATYFGAF KVRDID. Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human sRANK Ligand. Anti-Human sRANK Ligand-specific antibody was purified by affinity chromatography and then biotinylated. Sandwich ELISA: To detect Human sRANK Ligand by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.25-1.0 μg/mL of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech Polyclonal Anti-Human sRANK Ligand (500-P133) as a capture antibody, allows the detection of at least 0.2-0.4 ng/well of Recombinant Human sRANK Ligand. Western Blot: To detect hsRANKL by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for Recombinant hsRANKL is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. 500-P133BT-1MG will be provided as 2 x 500 μg
This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found.Specifications
| RANKL (soluble) | |
| ELISA, Western Blot | |
| Biotin | |
| Rabbit | |
| Human | |
| O14788 | |
| 8600 | |
| E.coli-derived, 20.0 kDa Recombinant Human sRANK Ligand. | |
| Antigen affinity chromatography | |
| TNFSF11 |
| 0.1-1.0 mg/mL | |
| Polyclonal | |
| Lyophilized | |
| RUO | |
| PBS with no preservative | |
| CD254; H-RANK-L; hRANKL2; Ly109l; M-Rank-L; ODF; OPG; OPG ligand; OPGL; OPTB2; Osteoclast differentiation factor; osteoprotegerin ligand; Rankl; rank-l; receptor activator of NF-kappaB ligand; receptor activator of nuclear factor kappa B ligand; receptor activator of nuclear factor kappa-B ligand; RP11-86N24.2; sOdf; srankl; TNF-related activation-induced cytokine; Tnfsf11; TNLG6B; Trance; tumor necrosis factor (ligand) superfamily member 11; tumor necrosis factor (ligand) superfamily, member 11; tumor necrosis factor ligand 6B; tumor necrosis factor ligand superfamily member 11; Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form; tumor necrosis factor superfamily member 11; tumor necrosis factor-related activation-induced cytokine | |
| TNFSF11 | |
| Primary | |
| -20°C |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.